Compare

Concord Medical Services Holdings Ltd vs Burning Rock Biotech Ltd

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Concord Medical Services Holdings Ltd CCM	Burning Rock Biotech Ltd BNR
Year ended	2025-12-31	2025-12-31
Revenue	460.51M CNY	539.57M CNY
Revenue growth (YoY)	+19.9%	+4.6%
Gross margin	5.6%	74.7%
Operating margin	-56.8%	-10.2%
Net margin	-20.2%	-10.3%
Net income	-92.81M CNY	-55.35M CNY
EPS (Diluted)	-0.71 CNY	n/a
Operating cash flow	-201.82M CNY	-28.44M CNY
Free cash flow	-258.15M CNY	-33.69M CNY
Cash & equivalents	297.79M CNY	478.39M CNY
Total assets	6.55B CNY	820.38M CNY
Total liabilities	4.70B CNY	285.11M CNY
Shareholders' equity	1.85B CNY	535.26M CNY
Return on year-end equity	-5.0%	-10.3%
Shares outstanding	n/a	n/a

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Concord Medical Services Holdings Ltd	Burning Rock Biotech Ltd
Latest	460.51M CNY Ended 2025-12-31	539.57M CNY Ended 2025-12-31
1 year earlier	383.96M CNY Ended 2024-12-31	515.82M CNY Ended 2024-12-31
2 years earlier	537.40M CNY Ended 2023-12-31	537.43M CNY Ended 2023-12-31
3 years earlier	472.08M CNY Ended 2022-12-31	563.24M CNY Ended 2022-12-31
4 years earlier	485.63M CNY Ended 2021-12-31	507.86M CNY Ended 2021-12-31